mRNA |
paclitaxel |
gCSI |
pan-cancer |
AAC |
-0.15 |
0.004 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
BRD-K85133207 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
XL765 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.005 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.005 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.006 |
mRNA |
C6-ceramide |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.006 |
mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.007 |